+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biotech Ingredients Market by Product Type, Application, Source, Form, Purity Grade, End User Industry - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010906
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biotech Ingredients Market grew from USD 48.93 billion in 2024 to USD 52.37 billion in 2025. It is expected to continue growing at a CAGR of 6.88%, reaching USD 72.98 billion by 2030.

Discovering the Evolution of Biotech Ingredients

Biotech ingredients have transcended their traditional roles, emerging as vital enablers across agriculture, food and beverage, cosmetics, animal nutrition, pharmaceutical formulations, and biofuel production. Driven by advances in molecular biology, enzyme engineering, and fermentation technologies, this domain is unlocking novel solutions that enhance product performance, drive sustainability, and meet evolving consumer demands. From precision nutrition supplements to eco-friendly crop protection agents, the influence of bio-based compounds is expanding, reshaping supply chains and stimulating cross-sector collaboration.

As regulatory frameworks tighten and consumers prioritize natural, transparent, and traceable ingredients, companies are intensifying research and development. Innovations in synthetic biology and computational design are accelerating the discovery of high-purity compounds, while strategic partnerships are streamlining commercial-scale manufacturing. This introduction sets the stage for a comprehensive examination of the pivotal shifts, regulatory pressures, segmentation insights, regional dynamics, and competitive strategies that will define the next chapter in biotech ingredient applications.

Navigating the Waves of Technological and Regulatory Transformation

In recent years, the landscape of biotech ingredients has experienced a profound metamorphosis fueled by breakthroughs in synthetic biology and artificial intelligence. Researchers are harnessing gene editing and machine learning algorithms to design bespoke enzymes and proteins with enhanced stability and specificity, effectively reducing development timelines and accelerating market entry. At the same time, digital supply chain platforms are enabling real-time visibility and predictive risk management, which mitigate disruptions and improve resource allocation.

Regulatory paradigms are also shifting, with agencies increasingly emphasizing lifecycle assessments and green chemistry principles. This regulatory momentum has catalyzed a wave of sustainable innovation, encouraging manufacturers to adopt renewable feedstocks and carbon-neutral processes. Consequently, industry players are reevaluating their operational footprints, integrating circular economy concepts, and forging alliances with academic institutions and technology providers. These transformative dynamics are converging to redefine competitive advantage, positioning agility, and innovation at the epicenter of long-term success.

Assessing the 2025 US Tariff Ripple Effect on Ingredient Sourcing

The introduction of new tariffs by the United States in 2025 has markedly altered the calculus of global ingredient sourcing, compelling stakeholders to reassess procurement strategies and cost structures. Increased duties on key feedstocks and finished bio-compounds have elevated landed costs, prompting supply chain managers to explore alternative origins, renegotiate long-term contracts, and accelerate nearshoring initiatives. As a result, domestic production capacities are receiving renewed investment, with several regional biomanufacturing clusters emerging to buffer future trade tensions.

Beyond direct financial impacts, the tariff environment has intensified price volatility and amplified the imperative for diversified supplier portfolios. Companies are leveraging scenario planning and dynamic hedging approaches to insulate operations from abrupt cost spikes. Additionally, collaborative frameworks among industry consortia and government bodies are facilitating tariff relief measures and streamlined customs procedures. In this evolving context, organizations that proactively adapt sourcing networks and maintain transparent cost modeling will safeguard margins and reinforce resilience against geopolitical headwinds.

Decoding Market Dynamics through Multifaceted Segmentation

A granular understanding of market dynamics emerges when dissecting biotech ingredients across product type, application, source, form, purity grade, and end user industry. In the realm of product type, the portfolio spans amino acids, enzymes, polysaccharides, proteins, and vitamins. Within enzymes, there is a clear delineation among carbohydrase, lipase, and protease, with carbohydrase further categorized into amylase and cellulase. Each of these biocatalysts serves distinct functions, from enhancing feed digestibility to enabling efficient biomass conversion in biofuel production.

Turning to application, their usage extends to agriculture, animal feed, biofuels, cosmetics, food and beverage, and pharmaceuticals. The food and beverage segment further specializes in bakery, dairy, and meat processing, where ingredient performance drives product quality and shelf life. Source classification highlights animal, microbial, and plant origins, with microbial sources subdivided into bacterial and fungal. This distinction underpins considerations around scalability, consistency, and regulatory adherence.

Proceeding to form factor, biotechnology ingredients present as capsules, liquids, and powders. The powder form is refined into granular and micronized variants to optimize solubility and bioavailability. Purity grade segmentation-food grade, pharmaceutical grade, technical grade-determines end-application suitability and regulatory barriers. Finally, end user industry mapping across agriculture, animal nutrition, biofuels, cosmetics, food processors, and pharmaceuticals reveals converging performance requirements and cross-industry innovation opportunities. Together, these segmentation lenses illuminate targeted growth strategies and product development pathways.

Regional Nuances Shaping Global Ingredient Demand

Regional nuances play a pivotal role in shaping demand patterns, regulatory landscapes, and competitive positioning. In the Americas, robust agricultural and animal nutrition sectors drive growing uptake of amino acids and enzymes for feed efficiency, while consumer interest in functional foods bolsters demand for high-purity polysaccharides and proteins. The region’s infrastructure for biomanufacturing and well-established logistics networks support rapid commercialization, although ongoing trade policy shifts require agile supply chain strategies.

Across Europe, the Middle East, and Africa, stringent environmental regulations and sustainability mandates are steering investments toward bio-based, low-carbon ingredients. European markets are particularly focused on certified organic and non-GMO sources, while the Middle East is expanding biorefinery capabilities to leverage abundant feedstocks. In Africa, public-private partnerships are catalyzing local production to reduce import dependencies, thereby strengthening food security and economic resilience.

The Asia-Pacific landscape is defined by a confluence of rising consumption in food and beverage, petrochemical-to-biofuel transitions, and burgeoning cosmetic markets. Rapid industrialization and supportive government incentives have accelerated capacity expansions in China, India, and Southeast Asia. Meanwhile, technology transfer agreements and joint ventures are enabling international players to navigate complex regulatory regimes and align with local content requirements, further intensifying competitive pressures.

Competitive Landscape and Strategic Player Profiles

The competitive landscape is characterized by a mix of established multinationals and specialized innovators. Leading enzyme producers have invested heavily in proprietary strain libraries and continuous manufacturing platforms, enabling scalable, cost-efficient outputs. Major ingredient suppliers are also forging strategic alliances with research institutions to access cutting-edge bioprocessing techniques and maintain a robust innovation pipeline.

Emerging biotech startups are leveraging modular bioreactor systems and digital bioprocess optimization to challenge traditional incumbents, introducing highly customized compounds and rapid-to-market solutions. These agile players excel in niche applications-such as targeted nutraceutical delivery systems and eco-friendly agricultural boosters-forcing larger companies to diversify portfolios and enhance R&D responsiveness.

Value chain integration is another distinguishing feature. Vertical players that control both feedstock production and downstream biomanufacturing achieve greater control over quality, cost, and sustainability metrics. As the pressure to demonstrate environmental stewardship intensifies, firms with transparent carbon footprints and validated life cycle analyses are gaining preferential access to premium contracts and long-term partnerships.

Strategic Roadmap for Industry Leaders in Biotech Ingredients

Industry leaders should accelerate investments in adaptive R&D platforms that harness machine learning for enzyme optimization and strain development. Embracing modular, continuous biomanufacturing units will reduce turnaround times and capital expenditures, supporting rapid scale-up when demand surges. To mitigate tariff-induced cost pressures, companies must cultivate diversified sourcing partnerships and explore localized production hubs in strategic regions.

Strategic collaborations between ingredient suppliers and end users can co-create tailored solutions, aligning functional benefits with formulators’ specifications for superior performance. Firms should also embed sustainability metrics into their product roadmaps, emphasizing renewable raw materials, energy-efficient processes, and transparent life cycle assessments to resonate with regulatory bodies and eco-conscious consumers.

Furthermore, leveraging digital supply chain platforms to gain end-to-end visibility will enable real-time risk detection and predictive mitigation strategies. By establishing cross-functional teams that integrate commercial, regulatory, and technical expertise, organizations can maintain agility, respond swiftly to market shifts, and secure competitive advantage.

Rigorous Methodology Ensuring Insightful Analysis

This analysis draws upon a rigorous dual-pronged methodology combining extensive secondary research with targeted primary interviews. The secondary phase encompassed a comprehensive review of industry publications, regulatory filings, patent databases, and technical journals to identify emerging trends, technological breakthroughs, and policy developments. Concurrently, primary consultations with senior executives, R&D scientists, supply chain directors, and regulatory specialists provided on-the-ground perspectives and validated interpretations of market dynamics.

Data triangulation techniques were applied to reconcile insights from disparate sources, ensuring robustness and minimizing bias. Analytical frameworks, including SWOT evaluations, PESTEL analyses, and Porter's Five Forces, structured the competitive and regulatory assessments. Segmentation matrices were then constructed to map product types, applications, sources, forms, purity grades, and end user industries against regional demand drivers and supplier capabilities.

Quality controls involved iterative peer reviews, fact verification against official databases, and coherence checks to maintain consistency in terminology and scope. This meticulous approach underpins the credibility of the findings and equips decision-makers with reliable intelligence to inform strategic planning.

Converging Insights and the Path Forward

The convergence of technological breakthroughs, evolving regulatory expectations, and shifting trade policies has created a dynamic environment for biotech ingredients. A nuanced segmentation framework reveals targeted growth opportunities, while regional analyses underscore distinct demand drivers and competitive advantages. From the competitive momentum among global multinationals and innovative startups to actionable roadmaps focused on sustainability and digitalization, the insights gathered here coalesce into a comprehensive narrative of transformation.

Industry participants that harness adaptive R&D, embrace diversified sourcing, and commit to transparent sustainability practices will be best positioned to capitalize on emerging market corridors. As the biotech ingredient landscape continues to evolve, the strategic choices made today in technology investment, partnership development, and regional footprint optimization will determine who leads tomorrow’s bio-based economy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Amino Acids
    • Enzymes
      • Carbohydrase
        • Amylase
        • Cellulase
      • Lipase
      • Protease
    • Polysaccharides
    • Proteins
    • Vitamins
  • Application
    • Agriculture
    • Animal Feed
    • Biofuels
    • Cosmetics
    • Food & Beverage
      • Bakery
      • Dairy
      • Meat Processing
    • Pharmaceuticals
  • Source
    • Animal
    • Microbial
      • Bacterial
      • Fungal
    • Plant
  • Form
    • Capsule
    • Liquid
    • Powder
      • Granular
      • Micronized
  • Purity Grade
    • Food Grade
    • Pharmaceutical Grade
    • Technical Grade
  • End User Industry
    • Agriculture
    • Animal Nutrition
    • Biofuels
    • Cosmetics
    • Food Processors
    • Pharmaceuticals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Novozymes A/S
  • Royal DSM N.V.
  • DuPont de Nemours, Inc.
  • Chr. Hansen Holding A/S
  • Lonza Group AG
  • Evonik Industries AG
  • Kerry Group plc
  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Roquette Frères

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biotech Ingredients Market, by Product Type
8.1. Introduction
8.2. Amino Acids
8.3. Enzymes
8.3.1. Carbohydrase
8.3.1.1. Amylase
8.3.1.2. Cellulase
8.3.2. Lipase
8.3.3. Protease
8.4. Polysaccharides
8.5. Proteins
8.6. Vitamins
9. Biotech Ingredients Market, by Application
9.1. Introduction
9.2. Agriculture
9.3. Animal Feed
9.4. Biofuels
9.5. Cosmetics
9.6. Food & Beverage
9.6.1. Bakery
9.6.2. Dairy
9.6.3. Meat Processing
9.7. Pharmaceuticals
10. Biotech Ingredients Market, by Source
10.1. Introduction
10.2. Animal
10.3. Microbial
10.3.1. Bacterial
10.3.2. Fungal
10.4. Plant
11. Biotech Ingredients Market, by Form
11.1. Introduction
11.2. Capsule
11.3. Liquid
11.4. Powder
11.4.1. Granular
11.4.2. Micronized
12. Biotech Ingredients Market, by Purity Grade
12.1. Introduction
12.2. Food Grade
12.3. Pharmaceutical Grade
12.4. Technical Grade
13. Biotech Ingredients Market, by End User Industry
13.1. Introduction
13.2. Agriculture
13.3. Animal Nutrition
13.4. Biofuels
13.5. Cosmetics
13.6. Food Processors
13.7. Pharmaceuticals
14. Americas Biotech Ingredients Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biotech Ingredients Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biotech Ingredients Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novozymes A/S
17.3.2. Royal DSM N.V.
17.3.3. DuPont de Nemours, Inc.
17.3.4. Chr. Hansen Holding A/S
17.3.5. Lonza Group AG
17.3.6. Evonik Industries AG
17.3.7. Kerry Group plc
17.3.8. Cargill, Incorporated
17.3.9. Archer Daniels Midland Company
17.3.10. Roquette Frères
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOTECH INGREDIENTS MARKET MULTI-CURRENCY
FIGURE 2. BIOTECH INGREDIENTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOTECH INGREDIENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOTECH INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOTECH INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOTECH INGREDIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AMYLASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CELLULASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY LIPASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BAKERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY DAIRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY MEAT PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY MICRONIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY TECHNICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 179. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 181. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 182. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 184. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 186. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 190. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 193. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 195. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 237. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 240. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 241. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 243. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 244. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 256. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 258. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 259. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 261. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 262. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 263. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 264. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 265. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 266. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 276. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 277. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 300. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 302. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 303. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 305. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 307. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 308. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 309. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 310. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 311. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 313. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 314. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 316. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 317. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 318. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 319. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 320. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 321. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 333. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 335. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 336. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 338. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 339. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 340. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 341. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 342. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 343. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 344. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 346. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRASE, 2018-2030 (USD MILLION)
TABLE 347. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 349. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 350. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY MICROBIAL, 2018-2030 (USD MILLION)
TABLE 351. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 352. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 353. POLAND B

Companies Mentioned

The companies profiled in this Biotech Ingredients market report include:
  • Novozymes A/S
  • Royal DSM N.V.
  • DuPont de Nemours, Inc.
  • Chr. Hansen Holding A/S
  • Lonza Group AG
  • Evonik Industries AG
  • Kerry Group plc
  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Roquette Frères

Methodology

Loading
LOADING...

Table Information